Competing risks analyses: objectives and approaches

被引:234
作者
Wolbers, Marcel [1 ,2 ]
Koller, Michael T. [3 ]
Stel, Vianda S. [4 ]
Schaer, Beat [5 ]
Jager, Kitty J. [4 ]
Leffondre, Karen [6 ]
Heinze, Georg [7 ]
机构
[1] Hosp Trop Dis, Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam
[2] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England
[3] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland
[4] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, ERA EDTA Registry, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland
[6] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France
[7] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria
基金
英国惠康基金;
关键词
Multiple failure causes; Combined endpoints; Cumulative incidence function; Cause-specific hazard function; Survival analysis; COMPOSITE OUTCOMES; PROBABILITIES; HAZARDS; MODEL;
D O I
10.1093/eurheartj/ehu131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies in cardiology often record the time to multiple disease events such as death, myocardial infarction, or hospitalization. Competing risks methods allow for the analysis of the time to the first observed event and the type of the first event. They are also relevant if the time to a specific event is of primary interest but competing events may preclude its occurrence or greatly alter the chances to observe it. We give a non-technical overview of competing risks concepts for descriptive and regression analyses. for descriptive statistics, the cumulative incidence function is the most important tool. For regression modelling, we introduce regression models for the cumulative incidence function and the cause-specific hazard function, respectively. We stress the importance of choosing statistical methods that are appropriate if competing risks are present. We also clarify the role of competing risks for the analysis of composite endpoints.
引用
收藏
页码:2936 / 2941
页数:6
相关论文
共 17 条
  • [1] Competing risks in epidemiology: possibilities and pitfalls
    Andersen, Per Kragh
    Geskus, Ronald B.
    de Witte, Theo
    Putter, Hein
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (03) : 861 - 870
  • [2] Time to move on from otime-to-first': should all events be included in the analysis of clinical trials?
    Anker, Stefan D.
    McMurray, John J. V.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (22) : 2764 - 2765
  • [3] Statistics notes - Survival probabilities (the Kaplan-Meier method)
    Bland, JM
    Altman, DG
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7172) : 1572 - 1572
  • [4] Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns
    Ferreira-Gonzalez, Ignacio
    Permanyer-Miralda, Gaieta
    Busse, Jason W.
    Bryant, Dianne M.
    Montori, Victor M.
    Alonso-Coello, Pablo
    Walter, Stephen D.
    Guyatt, Gordon H.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (07) : 651 - 657
  • [5] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [6] Composite outcomes in randomized trials - Greater precision but with greater uncertainty?
    Freemantle, N
    Calvert, M
    Wood, J
    Eastaugh, J
    Griffin, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19): : 2554 - 2559
  • [7] Gray B., 2013, SUBDISTRIBUTION ANAL
  • [8] Actual and actuarial probabilities of competing risks: Apples and lemons
    Grunkemeier, Gary L.
    Jin, Ruyun
    Eijkemans, Marinus J. C.
    Takkenberg, Johanna J. M.
    [J]. ANNALS OF THORACIC SURGERY, 2007, 83 (05) : 1586 - 1592
  • [9] Kleinbaum DG, 2011, SURVIVAL ANAL SELF L, VThird
  • [10] Kohl M, 2013, PSHREG SAS MACRO PRO